In plain English, CYP450 is a family of enzymes that helps your body process many drugs. A useful comparison is grapefruit: the FDA explains that grapefruit can block intestinal CYP3A4, which can let more of certain oral medications enter the bloodstream and stay there longer. That is why some labels warn patients to avoid grapefruit. Cannabis is not grapefruit, but the analogy helps: if a product changes the enzymes or transporters involved in drug handling, blood levels can shift up or down.

Cannabis gets talked about like it’s one big category: plant, oil, gummies, vape, done. But when the conversation turns to epilepsy, the real story is a lot more specific. In plain English: the FDA has not approved “cannabis” broadly for epilepsy. What it has approved is Epidiolex, a prescription oral solution made with purified cannabidiol (CBD), for a short list of seizure disorders. That distinction matters—a lot.

Here’s the Green Dragon-style takeaway up front: this is general cannabis education, not medical advice. If epilepsy is part of your life—or part of your family’s life—the safest move is to treat cannabinoids like real compounds with real upside, real risks, and real interaction potential. That means neurologist first, product second. Green Dragon’s own patient education leans the same way: practical, measured, and safety-first, especially when medications and complex conditions are involved.